Literature DB >> 7588830

Combined effect of human neutrophils, ceftazidime and granulocyte colony-stimulating factor on killing of Escherichia coli.

F D Daschner1, H Grundmann, K Anding, S Lemmen.   

Abstract

The combination effect of subinhibitory and inhibitory concentrations of ceftazidime, granulocyte colony-stimulating factor (G-CSF) and polymorphonuclear leukocytes (PMNL) against Escherichia coli was investigated. PMNL obtained from healthy volunteers were incubated with different concentrations of G-CSF and ceftazidime for 180 min. The addition of 0.25 x MIC of ceftazidime or 1 x MIC significantly enhanced the bactericidal activity of PMNL. G-CSF at a concentration of 6,000 units/ml led to only a slight improvement in the bactericidal activity of PMNL. The combination of 6,000 units/ml G-CSF and ceftazidime in inhibitory as well as subinhibitory concentrations, however, showed a significant synergistic effect (p < 0.01) on the antibacterial activity of PMNL during the entire incubation period. Combinations of G-CSF and antibiotics could therefore be beneficial for infected patients, especially those with impaired cellular host defence.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7588830     DOI: 10.1007/BF02113435

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  15 in total

1.  Therapeutic efficacy of granulocyte colony-stimulating factor alone and in combination with antibiotics against Pseudomonas aeruginosa infections in mice.

Authors:  H Yasuda; Y Ajiki; T Shimozato; M Kasahara; H Kawada; M Iwata; K Shimizu
Journal:  Infect Immun       Date:  1990-08       Impact factor: 3.441

2.  Effect of combination therapy with recombinant human granulocyte colony-stimulating factor (rG-CSF) and antibiotics in neutropenic mice unresponsive to antibiotics alone.

Authors:  M Matsumoto; S Matsubara; T Yokota
Journal:  J Antimicrob Chemother       Date:  1991-09       Impact factor: 5.790

3.  Synergy of ceftazidime and human macrophages on phagocytosis and killing of Staphylococcus aureus and Pseudomonas aeruginosa.

Authors:  A M Cuffini; N A Carlone; L Xerri; M F Pizzoglio
Journal:  J Antimicrob Chemother       Date:  1987-08       Impact factor: 5.790

4.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

5.  Potentiation of phagocytosis of pathogenic bacteria by exposure to low concentrations of antibiotics.

Authors:  C G Gemmell
Journal:  J Antimicrob Chemother       Date:  1984-05       Impact factor: 5.790

6.  Recombinant human granulocyte colony-stimulating factor enhances superoxide release in human granulocytes stimulated by the chemotactic peptide.

Authors:  S Kitagawa; A Yuo; L M Souza; M Saito; Y Miura; F Takaku
Journal:  Biochem Biophys Res Commun       Date:  1987-05-14       Impact factor: 3.575

7.  The beneficial effect of granulocyte colony-stimulating factor (G-CSF) in combination with gentamicin on survival after Pseudomonas burn wound infection.

Authors:  G M Silver; R L Gamelli; M O'Reilly
Journal:  Surgery       Date:  1989-08       Impact factor: 3.982

8.  Enhancement of in vitro bactericidal activity of neutrophils from trauma patients in the presence of granulocyte colony-stimulating factor.

Authors:  K Anding; A Kropec; E Schmidt-Eisenlohr; A Benzing; K Geiger; F Daschner
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-02       Impact factor: 3.267

9.  In vivo activation of neutrophil function in hamsters by recombinant human granulocyte colony-stimulating factor.

Authors:  A M Cohen; D K Hines; E S Korach; B J Ratzkin
Journal:  Infect Immun       Date:  1988-11       Impact factor: 3.441

Review 10.  Antimicrobial drugs, microorganisms, and phagocytes.

Authors:  P J van den Broek
Journal:  Rev Infect Dis       Date:  1989 Mar-Apr
View more
  3 in total

Review 1.  Melioidosis: epidemiology, pathophysiology, and management.

Authors:  Allen C Cheng; Bart J Currie
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

2.  Effects of recombinant granulocyte-colony stimulating factor administration during Mycobacterium avium infection in mice.

Authors:  A S Gonçalves; R Appelberg
Journal:  Clin Exp Immunol       Date:  2001-05       Impact factor: 4.330

3.  Granulocyte colony-stimulating factor and an in vitro whole blood model of melioidosis.

Authors:  A C Cheng; P Dasari; B J Currie
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-02-19       Impact factor: 3.267

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.